Trending Topics

Tag: Biotechnology
over 1 year ago
wsj.com

Biotech May Be the Next U.S.-China Battleground

Investors in Chinese biotech—and perhaps their U.S. clients too—should be prepared for a rough ride.

Read Full Article
about 2 years ago
wsj.com

U.S. Businesses Sour on Saudi Arabia in Blow to Crown Prince’s Growth Plans

Surprise tax hits, unpaid bills and stolen intellectual property are undoing the government’s effort to shift the kin...

Read Full Article
over 2 years ago
wsj.com

As Omicron Surges, Africa’s Covid-19 Vaccination Drive Sputters

After two years of struggling to procure coronavirus vaccines, the continent with the fewest Covid-19 inoculations is...

Read Full Article
over 2 years ago
wsj.com

China-U.S. Tension Mars Biotech Giant BeiGene’s Shanghai Debut

BeiGene tumbled 16% in its mainland trading debut, after raising $3.5 billion and becoming the first company to be tr...

Read Full Article
over 2 years ago
wsj.com

Behind Israel’s Swift Rollout of Covid-19 Vaccine Boosters

Israel’s public health experts have been consistently ahead of their global counterparts in efforts to fight Covid-19...

Read Full Article
over 2 years ago
wsj.com

More Seed Capital for Syngenta Could Help Feed China

The company’s coming IPO would provide a boost to STAR, China’s homegrown Nasdaq-style market, as well as another of ...

Read Full Article
over 2 years ago
wsj.com

Australia’s Delta Outbreak Shows Vaccines Protect Against Hospitalization

Early data from Australia’s outbreak of the Covid-19 Delta variant suggest that two vaccine doses offer significant p...

Read Full Article
almost 3 years ago
wsj.com

BioNTech’s Covid-19 Vaccine Success Sparks Investments in German Biotech

After the company partnered with Pfizer on a vaccine, investors last year poured $3.7 billion into a sector that has ...

Read Full Article
almost 3 years ago
wsj.com

WSJ News Exclusive | China Plans to Approve First Foreign Covid-19 Vaccine by July

The final timing of Beijing’s decision to green light the BioNTech shot will depend in part on approval of Chinese va...

Read Full Article
almost 3 years ago
wsj.com

Australia Expects Big Delays to Covid-19 Vaccine Rollout

Australia expects its Covid-19 vaccination campaign to be delayed by months because of concerns over side effects fro...

Read Full Article
about 3 years ago
techradar.com

China five-year plan aims for global AI and quantum supremacy

China wants to help its companies break their dependence on the US

Read Full Article
about 3 years ago
wsj.com

Investors Take Profits on Short-Squeezed Stocks Pearson, Evotec, Klepierre

Investors dumped heavily shorted stocks in Europe Thursday in a bid to profit from share prices that have been pumped...

Read Full Article
about 3 years ago
wsj.com

Another Covid-19 Vaccine Developer Gets Help From Big Pharma

Pharmaceuticals giant Bayer is joining forces with Germany’s CureVac to support the biotech firm in its development o...

Read Full Article
over 3 years ago
wsj.com

European Union Eyes Late-December Covid-19 Vaccine Rollout

The 27-country bloc intends to start vaccinating citizens against Covid-19 as soon as Dec. 27, following criticism ov...

Read Full Article
over 3 years ago
wsj.com

Chinese Covid-19 Vaccine Is 86% Effective, U.A.E. Trial Shows

The interim trial results are a boost for China as it races with Western nations to develop vaccines and slow the spr...

Read Full Article
over 3 years ago
wsj.com

A Covid-19 Vaccine Would Boost the Global Economy, But Not All at Once

While a successful vaccine could indeed give the economy a shot in the arm in 2021, say economists, it will take long...

Read Full Article
over 3 years ago
wsj.com

U.S. Firms Get Another Boost From China

Coca-Cola, GM, Estee Lauder and others got a lift in the third quarter from Chinese consumers spending big, even as a...

Read Full Article

Copyright © 2023 All rights reserved. Legitimate Limited.